Benzalkonium Chloride (Turn Therapeutics)

苯扎氯铵 (Turn Therapeutics)

Report date: 2025/07/18 17:54:06

Base Information

Drug NameBenzalkonium Chloride (Turn Therapeutics)
Drug Alias NameBenzalkonium Chloride 0.0065% (Turn Therapeutics)GX-03
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)EczemaDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPanamaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTurn Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesTurn Therapeutics
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)EczemaDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A